from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3088/tgs4

LFCtreatmentdescriptionclass of inhibitor

-0.333

Amikacinug/mL Amikacintranslation

-0.671

Cap5-10ug/mL Capreomycintranslation

-1.123

Rox10-50 ug/mL Roxithromycintranslation

-0.326

SM2-5 ug/mL Streptomycintranslation

-1.350

Tet5-10 ug/mL Tetracyclinetranslation

-0.185

Rif0.2-5ug/mL Rifampicintranscription

0.288

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.405

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.532

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.024

CPZ10-50 ug/mL Chlorpromazinerespiration

0.604

Clofazimine10-13 ug/mL Clofaziminerespiration

0.152

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.234

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.419

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.179

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.205

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.379

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.430

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.736

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.546

KCN5-20 ug/mL Potassium cyaniderespiration

1.175

NaN30.2-2 mM Sodium aziderespiration

-0.749

Nigericin50 uM Nigericinrespiration

0.703

TRC10-150 ug/mL Triclosanrespiration

-0.612

TRZ10-25 ug/mL Thioridazinerespiration

-0.783

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.352

menadione6-10 ug/mL Menadionerespiration

0.820

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.243

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.610

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.728

NRP_1Non-replicating persistence stage 1dosRassociated

0.079

Amp0.2mg/mL AmpicillincellWall

-0.296

Cephalexin20-100 ug/mL CephalexincellWall

-0.338

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.396

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.296

EMB10-20 ug/mL EthambutolcellWall

-0.511

Eta12-40 ug/mL EthionamidecellWall

-0.636

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.277

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.747

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.743

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.860

BZA0.12 mg/mL BenzamidearomaticAmides

0.768

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.071

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.115

H2O24 mM hydrogen peroxideDNAdamaging

-0.307

Levo10 ug/mL LevofloxacinDNAdamaging

-0.206

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.200

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.222

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.416

UVUV-irradiationDNAdamaging

0.289

ARP41-4 ug/mL Antitubercular compound ARP4?

5.470

Antimycin12.5-50 ug/mL Antimycin A?

-0.829

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.139

PA_110-50 ug/mL Antitubercular compound PA-1?

0.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.390

PA8240.2-2 ug/mL PA-824?

0.220

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.112

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.718

Verapamil50 uM Verapamil?

-0.641

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.062

methoxatin10-20 ug/mL Methoxatin?